Search

Your search keyword '"Cozzani, Adeline"' showing total 10 results
Start Over Author "Cozzani, Adeline"
10 results on '"Cozzani, Adeline"'

3. MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma

Author

Bou Issa, Lama Hasan, primary, Fléchon, Léa, additional, Laine, William, additional, Ouelkdite, Aicha, additional, Gaggero, Silvia, additional, Cozzani, Adeline, additional, Tilmont, Remi, additional, Chauvet, Paul, additional, Gower, Nicolas, additional, Pistofidis, Romanos Sklavenitis, additional, Brinster, Carine, additional, Thuru, Xavier, additional, Touil, Yasmine, additional, Quesnel, Bruno, additional, Mitra, Suman, additional, Ghobrial, Irene M., additional, Kluza, Jérôme, additional, and Manier, Salomon, additional

Published
2024
Full Text
View/download PDF

4. A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells

Author

Nasrallah, Rabab, Imianowski, Charlotte J., Bossini-Castillo, Lara, Grant, Francis M., Dogan, Mikail, Placek, Lindsey, Kozhaya, Lina, Kuo, Paula, Sadiyah, Firas, Whiteside, Sarah K., Mumbach, Maxwell R., Glinos, Dafni, Vardaka, Panagiota, Whyte, Carly E., Lozano, Teresa, Fujita, Toshitsugu, Fujii, Hodaka, Liston, Adrian, Andrews, Simon, Cozzani, Adeline, Yang, Jie, Mitra, Suman, Lugli, Enrico, Chang, Howard Y., Unutmaz, Derya, Trynka, Gosia, and Roychoudhuri, Rahul

Published
2020
Full Text
View/download PDF

5. IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein

Author

Gaggero, Silvia, primary, Martinez-Fabregas, Jonathan, additional, Cozzani, Adeline, additional, Fyfe, Paul K., additional, Leprohon, Malo, additional, Yang, Jie, additional, Thomasen, F. Emil, additional, Winkelmann, Hauke, additional, Magnez, Romain, additional, Conti, Alberto G., additional, Wilmes, Stephan, additional, Pohler, Elizabeth, additional, van Gijsel Bonnello, Manuel, additional, Thuru, Xavier, additional, Quesnel, Bruno, additional, Soncin, Fabrice, additional, Piehler, Jacob, additional, Lindorff-Larsen, Kresten, additional, Roychoudhuri, Rahul, additional, Moraga, Ignacio, additional, and Mitra, Suman, additional

Published
2022
Full Text
View/download PDF

8. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity

Author

Martinez-Fabregas, Jonathan, primary, Wilmes, Stephan, additional, Wang, Luopin, additional, Hafer, Maximillian, additional, Pohler, Elizabeth, additional, Lokau, Juliane, additional, Garbers, Christoph, additional, Cozzani, Adeline, additional, Fyfe, Paul K, additional, Piehler, Jacob, additional, Kazemian, Majid, additional, Mitra, Suman, additional, and Moraga, Ignacio, additional

Published
2019
Full Text
View/download PDF

9. Author response: Kinetics of cytokine receptor trafficking determine signaling and functional selectivity

Author

Martinez-Fabregas, Jonathan, primary, Wilmes, Stephan, additional, Wang, Luopin, additional, Hafer, Maximillian, additional, Pohler, Elizabeth, additional, Lokau, Juliane, additional, Garbers, Christoph, additional, Cozzani, Adeline, additional, Fyfe, Paul K, additional, Piehler, Jacob, additional, Kazemian, Majid, additional, Mitra, Suman, additional, and Moraga, Ignacio, additional

Published
2019
Full Text
View/download PDF

10. Optimizing CAR-NK Cell Transduction and Expansion: Leveraging Cytokine Modulation for Enhanced Performance.

Author

Ingegnere T, Segain B, Cozzani A, Carlsten M, Mitra S, and Gaggero S

Subjects
Humans, Lentivirus genetics, Genetic Vectors, Cell Culture Techniques methods, Killer Cells, Natural immunology, Receptors, Chimeric Antigen immunology, Receptors, Chimeric Antigen genetics, Receptors, Chimeric Antigen metabolism, Cytokines metabolism, Transduction, Genetic methods, Immunotherapy, Adoptive methods
Abstract

Cellular immunotherapy has emerged as one of the most potent approaches to treating cancer patients. Adoptive transfer of chimeric antigen receptor (CAR) T cells as well as the use of haploidentical natural killer (NK) cells can induce remission in patients with lymphoma and leukemia. Although the use of CAR T cells has been established, this approach is currently limited for wider use by the risk of severe adverse events, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. Moreover, the risk of triggering graft vs host reactions in settings of allogeneic T cell infusion limits the use to autologous CAR T cells if advanced CRISPR engineering is not applied. In contrast, NK cell-based cancer immunotherapy has emerged as a safe approach even in allogeneic settings. However, efficient transduction of primary blood NK cells with vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped lentivirus commonly used for T cell modification remains challenging. This article presents a detailed method that significantly enhances the transduction efficiency of NK cells by utilizing a short-term culture in cytokine-supplemented medium. It also encompasses the preparation of high-titer and high-quality lentiviral particles for optimal NK cell transduction. Overall, this protocol details the step-by-step culture of NK cells in cytokine-supplemented medium, their transduction with VSV-G lentiviral vectors, and subsequent expansion for functional assays. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Isolation of NK cells from human peripheral blood mononuclear cells (PBMCs) Basic Protocol 2: NK cell expansion and transduction with lentivirus for generating CAR-NK cells Support Protocol 1: Plasmid amplification Support Protocol 2: Lentivirus preparation Support Protocol 3: Lentivirus titration., (© 2024 Wiley Periodicals LLC.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results